The Anorexiant Market refers to the pharmaceutical sector that deals with the development, production, and sale of medications or drugs used for appetite suppression and weight management. Anorexiants are a type of medication that helps reduce appetite, leading to decreased food intake and potential weight loss.
The market for anorexiants primarily focuses on individuals who struggle with obesity or overweight conditions and need medical intervention to achieve weight loss. These medications are typically prescribed by healthcare professionals and used in combination with diet and exercise programs.
It’s important to note that as an AI language model, I don’t have access to real-time data or market statistics beyond my knowledge cutoff in September 2021. Therefore, I cannot provide you with the latest information on the current state or trends in the anorexiant market. For up-to-date and accurate market insights, I recommend consulting industry reports, market research firms, or healthcare professionals.
Curious about the effects of recent acquisitions in the anorexiant market industry? Download our Sample Report now @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9574
In 2022, the size of the global anorexiant market was estimated to be over $1 billion. The anorexiants market is anticipated to grow at a CAGR of 5.3% during the forecast period. Growth is to blame for the increased prevalence of obesity. According to CDC data released in May 2022, between 1990 and 2000, 2017 and 2020, the United States increased from 35 to 41.9%.
By 2021, the WHO predicts that approximately 600 million adults and 39 million children under the age of five would be obese. This issue is raising healthcare costs, which is anticipated to fuel the need for anorexics in the coming years.
Anorexiants: Market Insights
Anorexiants are used to treat obesity. Anorexiants suppress hunger by boosting a person’s basal metabolic rate. Anorexiants also boost cellular glucose uptake while lowering fat absorption from food.
According to the World Health Organisation, more than 1.9 billion people aged 18 and older were classified as overweight in 2016, with 650 million adults classified as obese. In addition, 41 million children under the age of five were found to be obese in 2016.
Anorexiants: Market Dynamics
Because of their utility in the treatment of obesity, anorexiants are expected to grow greatly in the market. Anorexiants can aid in weight loss by reducing calorie intake, particularly in patients with a BMI of 30 or higher.
The market is expected to grow because anorexiants are used to treat obesity. Anorexics, on the other hand, are restricted in some ways. Anorexiants can have a number of unpleasant side effects, including sleepiness, elevated blood pressure, restlessness, drug dependence, and so on, which can have an effect on the Anorexiants market. Long-term use of anorexiants also leads to drug addiction, which can lead to health concerns later in life.
Don’t hesitate to contact our analyst if you have any questions @ https://www.futuremarketinsights.com/ask-question/rep-gb-9574
Anorexiants Market: Overview
Because of the rising prevalence of obesity around the world, the Anorexiants industry is expected to produce significant income in the next years. Orlistat, lorcaserinER, liraglutide, naltrexone/bupropion ER, lorcaserin, and phentermine/topiramate ER are some of the anorexiants used to treat obesity. Many drugs have been approved by the FDA for the treatment of obesity, therefore the market for anorexiants is projected to grow in the coming years.
According to the Centres for Disease Control and Prevention, the obesity prevalence in the United States is expected to be 39.8%, affecting 93.3 million people. The global Anorexiants market will grow as the prevalence and incidence of weight gain and obesity rise.
Anorexiants Market: Region-wise Outlook
Geographically, the global Anorexiants market is segmented into seven primary regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific except Japan, Japan, and the Middle East and Africa. Because of the rising prevalence of obesity and the rapid adoption of new medications, North America is expected to hold the highest proportion of the Anorexiants market.
Furthermore, the expansion of healthcare facilities and technological improvements have substantially aided the Anorexiants industry. Europe is predicted to make a considerable contribution to the Anorexiants market due to increased drug launches and easier drug approval, resulting in market growth.
Anorexiants Market: Key Players
Some of the key players present across the value chain of the global Anorexiants market are Akrimax Pharmaceuticals, LLC, Teva Pharmaceuticals, Janssen Ortho, LLC, Roche Pharmaceuticals, Arena Pharmaceuticals GmbH, Novo Nordisk A/S, Abbott Pharmaceuticals PR Ltd., Epic Pharma, LLC. Patheon Pharmaceuticals Inc. Catalent Pharma Solutions, LLC, Recordati Rare Diseases Inc., MOVA Pharmaceuticals.
Act Now to Explore In-Depth Market Analysis: Get Exclusive Purchase Now to Access @ https://www.futuremarketinsights.com/checkout/9574
Key Segments Profiled in the Anorexiants Market Survey
By Drug Class:
- Catecholaminesb
- Serotoninb
By Route of Administration:
- Oral
- Subcutaneous
By End User:
- Institutional sales
- Hospitals
- Clinics
- Retail sales
- Online pharmacies
- Mail Order Pharmacies
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
